We are live on ! Find out more
CBT

CoreFirst Bank & Trust Portfolio holdings

AUM $201M
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+24.67%
3 Year Est. Return
+61.4%
5 Year Est. Return
+84.2%
10 Year Est. Return
AUM
$168M
AUM Growth
-$4.86M
Cap. Flow
+$1.54M
Cap. Flow %
0.92%
Top 10 Hldgs %
36.66%
Holding
357
New
15
Increased
41
Reduced
78
Closed
3

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.53%
2 Technology 13.67%
3 Consumer Staples 13.47%
4 Healthcare 6.13%
5 Financials 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUMN icon
351
Lumen
LUMN
$7.16B
$1.75K ﹤0.01%
330
ECG
352
Everus Construction Group
ECG
$6.1B
$1.64K ﹤0.01%
+25
New +$1.57K
KLG
353
DELISTED
WK Kellogg Co
KLG
$450 ﹤0.01%
25
OXY.WS icon
354
Occidental Petroleum Corp Warrants
OXY.WS
$37.2B
$386 ﹤0.01%
14
-19
-58% -$544
DJUN icon
355
FT Vest US Equity Deep Buffer ETF June
DJUN
$358M
-2,780
Closed -$118K
MLPX icon
356
Global X MLP & Energy Infrastructure ETF
MLPX
$3.65B
-9,020
Closed -$491K
RYLD icon
357
Global X Russell 2000 Covered Call ETF
RYLD
$1.37B
-53,290
Closed -$861K

Similar funds

CoreFirst Bank & Trust's Q4 2024 Portfolio in Review

As of Q4 2024, CoreFirst Bank & Trust held 357 positions worth $168M, down 2.8% from $173M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CoreFirst Bank & Trust's Q4 2024 filing shows 15 new, 41 increased, 78 reduced and 3 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US Small-Cap Index Fund: 10,691 shares worth $1.22M. The largest sale was VanEck Pharmaceutical ETF, an estimated $1.02M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 40% a quarter earlier, followed by Technology and Consumer Staples.

  • CoreFirst Bank & Trust's largest Q4 2024 buy was Vanguard FTSE All-World ex-US Small-Cap Index Fund: 10,691 shares worth $1.22M.
  • CoreFirst Bank & Trust added most to FT Vest US Equity Deep Buffer ETF September in Q4 2024, an estimated $1.09M increase.
  • CoreFirst Bank & Trust's biggest Q4 2024 reduction was VanEck Pharmaceutical ETF, cutting an estimated $1.02M.
  • CoreFirst Bank & Trust fully exited Global X Russell 2000 Covered Call ETF in Q4 2024, selling an estimated $861K.
  • CoreFirst Bank & Trust's ten largest holdings make up 37% of its $168M portfolio in Q4 2024.
  • CoreFirst Bank & Trust opened 15 new positions and closed 3 in Q4 2024.
  • CoreFirst Bank & Trust's portfolio value fell 2.8% quarter-over-quarter to $168M.

Based on CoreFirst Bank & Trust's 13F filing for Q4 2024, filed 11 Feb 2025.